- Report
- August 2025
- 367 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 476 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 282 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 286 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 371 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 463 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 475 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 364 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 576 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 477 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 268 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 376 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 175 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 272 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 268 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 386 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 568 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 395 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 281 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more